UCLA has several ongoing multi-year projects supported by NIH focused on developing new biomaterials and molecular therapeutic strategies to repair craniofacial and orthopedic skeletal defects. Applicants should have a recent Ph.D. in biology, bioengineering, materials science, chemistry or related field with strong research track records in one or more of the following areas: biomaterial synthesis and characterization, tissue engineering, stem cell biology, molecular biology, gene therapy. Preference will be given to applicants with a strong experimental background in bone regeneration or exosome therapy.
We use cookies on this site to enhance your experience. By using our website you accept our use of cookies.
Cookies
YourMembership uses cookies for your convenience and security. Cookies are text files stored on the browser of your computer and are used to make your experience on web sites more personal and less cumbersome. You may choose to decline cookies if your browser permits, but doing so may affect your ability to access or use certain features of this site. Please refer to your web browser's help function for assistance on how to change your preferences.